{"nct_id":"NCT05367401","title":"A Study of Sabatolimab and Magrolimab-based Treatment in AML or Higher Risk MDS Participants","status":"WITHDRAWN","status_verified_date":"2024-04","start_date":"2024-12-20","start_date_type":"ESTIMATED","primary_completion_date":"2029-10-26","primary_completion_date_type":"ESTIMATED","completion_date":"2029-10-26","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}